Jane Street
GNOM icon

Jane Street’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Jane Street’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$702K Buy
16,038
+3,425
+27% +$158K ﹤0.01% 7272
2025
Q4 		$573K Sell
12,613
-2,327
-16% -$103K ﹤0.01% 7379
2025
Q3 		$580K Buy
14,940
+6,934
+87% +$251K ﹤0.01% 7529
2025
Q2 		$270K Sell
8,006
-27,922
-78% -$884K ﹤0.01% 8043
2025
Q1 		$1.14M Buy
35,928
+2,577
+8% +$97.8K ﹤0.01% 5326
2024
Q4 		$1.3M Buy
33,351
+1,555
+5% +$65.3K ﹤0.01% 4913
2024
Q3 		$1.43M Sell
31,796
-4,138
-12% -$185K ﹤0.01% 5156
2024
Q2 		$1.5M Buy
35,934
+23,941
+200% +$1M ﹤0.01% 5008
2024
Q1 		$546K Sell
11,993
-136,211
-92% -$6.2M ﹤0.01% 6502
2023
Q4 		$6.85M Buy
148,204
+136,436
+1,159% +$5.56M ﹤0.01% 2419
2023
Q3 		$479K Buy
+11,768
New +$536K ﹤0.01% 6364
2023
Q1 		– Sell
-9,517
Closed -$482K – 9349
2022
Q4 		$482K Buy
+9,517
New +$491K ﹤0.01% 6200
2022
Q2 		– Sell
-9,581
Closed -$576K – 10084
2022
Q1 		$576K Buy
+9,581
New +$604K ﹤0.01% 7199
2021
Q1 		– Sell
-23,124
Closed -$2.19M – 9281
2020
Q4 		$2.19M Buy
23,124
+14,464
+167% +$1.21M ﹤0.01% 3329
2020
Q3 		$623K Buy
+8,660
New +$620K ﹤0.01% 4825
2020
Q1 		– Sell
-7,645
Closed -$477K – 5556
2019
Q4 		$477K Buy
+7,645
New +$438K ﹤0.01% 3743
2019
Q3 		– Sell
-6,304
Closed -$381K – 5320
2019
Q2 		$381K Buy
+6,304
New +$359K ﹤0.01% 3916

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $236M AUM 12.89% 1-Year Est. Return

Jane Street's GNOM Position: Q1 2026 in Review

Jane Street increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 27% in Q1 2026, buying an estimated $158K and bringing the position to 16,038 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #7272.

Jane Street first reported a position in GNOM in Q2 2019 and has held it in 17 quarters since. The position peaked at $6.85M in Q4 2023. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Jane Street held 16,038 shares of Global X Genomics & Biotechnology ETF worth $702K as of Q1 2026.
  • Jane Street bought 3,425 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $158K.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7272 holding.
  • Jane Street first reported a position in Global X Genomics & Biotechnology ETF in Q2 2019 and has held it in 17 quarters since.
  • Jane Street's Global X Genomics & Biotechnology ETF position peaked at $6.85M in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.